Rapid Micro Biosystems logo
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
December 07, 2022 16:30 ET | Rapid Micro Biosystems, Inc.
LOWELL, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company, providing mission critical automation...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments
December 06, 2022 16:05 ET | Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $34.8 Million -- -- Signed $26 Million in Net New Business Orders Resulting in a Backlog of $147 Million, an Increase of 23% Year-Over-Year -- -- Mammalian...
Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022
November 29, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Oksana Lukash as Vice President, People
November 16, 2022 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
November 02, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in RBC Global CDMO Conference
September 27, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
September 22, 2022 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
AMR Logo.png
Global Atopic Dermatitis Market to Reach $22.6 Billion by 2031: Allied Market Research
September 13, 2022 20:00 ET | Allied Market Research
Portland, OR, Sept. 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Atopic Dermatitis Market generated $5.3 billion in 2021, and is projected to...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
September 06, 2022 16:05 ET | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Logo padrão.png
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
September 05, 2022 08:30 ET | Biotimize - Biotechnology as a Service
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Biotimize, a functional growth-stage biotechnology as a service (BaaS) company with a mission to transform lives through biotechnology, today...